Enovis | ENOV - Cost Of Sales


Enovis reported $265.09M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Alcidion AUD 6.82M 1.16M Dec/2025
Ambu A/S DKK 625M 14M Mar/2026
Amplifon EUR 527.19M 77.51M Jun/2026
Apollo Hospitals Enterprise Ltd INR 38.32B 2.06B Jun/2026
Coloplast 2.31B 110M Dec/2025
Convatec Group USD 515.3M 270.15M Dec/2024
Diasorin EUR 101M 7.58M Mar/2026
Enovis USD 265.09M 476K Jun/2026
Gulf Medical Proj AED 147.27M 3.78M Mar/2026
Hoya 209.52B 170.6B Jun/2026
Med Life RON 171.54M 112.24M Mar/2026
Oriola-kd EUR 11.4M 450.2M Mar/2026
Rede D'or Sao Luiz BRL 6.37B 4.76B Jun/2026
Siemens Healthineers EUR 3.31B 226M Jun/2026
Sonova Holding CHF 539.4M 11.5M Dec/2025